| Date Filed | Type | Description |
| 10/05/2023 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 16,600 options to buy
@ $3.555, valued at
$59k
|
|
| 10/05/2023 |
3
| SHERMAN JEFFREY W (Director) has filed a Form 3 on Larimar Therapeutics, Inc. |
| 07/18/2023 |
4
| Clayton Russell (Chief Medical Officer) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 180,000 options to buy
@ $3.22, valued at
$579.6k
|
|
| 07/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/18/2023 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $3.7263, valued at
$18.6k
|
|
| 05/18/2023 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $3.705, valued at
$18.5k
|
|
| 05/18/2023 |
4
| Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 2,750 shares
@ $3.73, valued at
$10.3k
|
|
| 05/11/2023 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 05/11/2023 |
4
| Truitt Joseph (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 05/11/2023 |
4
| Hamilton Thomas Edward (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 05/11/2023 |
4
| LEFF JONATHAN S (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 05/11/2023 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 02/09/2023 |
4
| Shankar Gopi (Chief Development Officer) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 180,000 options to buy
@ $5.88, valued at
$1.1M
|
|
| 02/09/2023 |
3
| Shankar Gopi (Chief Development Officer) has filed a Form 3 on Larimar Therapeutics, Inc. |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 2,777,777 shares
@ $3.15, valued at
$8.7M
|
|
| 09/20/2022 |
3
| DEERFIELD PARTNERS, L.P. (10% Owner) has filed a Form 3 on Larimar Therapeutics, Inc. |
| 09/20/2022 |
4
| Hamilton Thomas Edward (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 317,460 shares
@ $3.15, valued at
$1000k
|
|
| 09/19/2022 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 31,746 shares
@ $3.15, valued at
$100k
|
|
| 09/19/2022 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 31,746 shares
@ $3.15, valued at
$100k
|
|
| 05/12/2022 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $2.92, valued at
$116.8k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Hamilton Thomas Edward (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $2.92, valued at
$24.2k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $2.92, valued at
$24.2k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Celano Michael (CFO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $8.75, valued at
$700k
|
|
| 01/20/2022 |
4
| BEN-MAIMON CAROLE (President and CEO) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 182,000 options to buy
@ $8.75, valued at
$1.6M
|
|
| 07/02/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 228,569 shares
@ $8.75, valued at
$2M
Bought 228,571 shares
@ $8.75, valued at
$2M
Bought 228,570 shares
@ $8.75, valued at
$2M
|
|
| 07/02/2021 |
4
| Hamilton Thomas Edward (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 56,710 shares
@ $8.75, valued at
$496.2k
|
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|